Back to the main directory
EarningsReview / Equity
- FY results first take: 2026 guide 3% ahead & share buyback by BNP Paribas
- Q4 Results - FY 26 Auto EBIT and FCF generation Outlook below cons. by BNP Paribas
- IP '26-30 update: mixed bag with short term below, but 2030 FOCF ahead by BNP Paribas
- Board appointments for Octave spin by BNP Paribas
- FY26 Trading update - Guidance confirmed, no changes expected by BNP Paribas
- FY25: in-line results, strong AM flows by BNP Paribas
- WIIT - Course solide, valorisation exigeante: WIIT aux stands by MidCap Partners
- Voltalia - Le recentrage commence à porter ses fruits by MidCap Partners
- Ekinops - 2026 démarre sur un Profit Warning ! by MidCap Partners
- INVEST SECURITIES - BIOPHYTIS : 6 mois de visibilité financière offerts via 2 opérations - ACHAT, OC 0,06€ vs 0,09€ by Invest Securities
- INVEST SECURITIES - ASSYSTEM : Potentiel baissier limité, mais momentum CT faible - NEUTRE vs VENTE, OC 40€ vs 38€ by Invest Securities
- ID Logistics - Disappointment on cash generation by MidCap Partners
- TFF Group - In Line by MidCap Partners
- Fill Up Media - Scalability Confirmed by MidCap Partners
- FY 2025 slightly below BBG consensus expectations by BNP Paribas
- Voltalia - The refocusing strategy is starting to deliver results by MidCap Partners
- Highlights from our Staples & Ingredients Conference Day 1 by BNP Paribas
- FY 2025 conference call: Talking to 2026 by BNP Paribas
- IEA March OMR: All eyes on the Strait of Hormuz by BNP Paribas
- ASMPT post 4Q25 result NDR takeaway by BNP Paribas
- Micro findings amidst macro headwinds by BNP Paribas
- Q4 Conference Call - Key Takeaways by BNP Paribas
- Still sniffing for a top-line inflection by BNP Paribas
- Q3 FY’26 First take: Solid revenue momentum, but margins weak. Capex upgraded by BNP Paribas
- Non material data changes by BNP Paribas